2,90 €
3,55 %heute
L&S, 21. Februar, 16:58 Uhr
ISIN
US64131A1051
Symbol
STIM
Berichte

Neuronetics, Inc. Aktie News

Neutral
GlobeNewsWire
ein Tag alt
MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release fourth quarter 2023 financial and operating results prior to market open on Tuesday, March 5th, 2024. The Com...
Neutral
GlobeNewsWire
9 Tage alt
Advancements provide workflow efficiencies for NeuroStar® TMS providers Advancements provide workflow efficiencies for NeuroStar® TMS providers
Neutral
GlobeNewsWire
15 Tage alt
MALVERN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced criteria changes by Lucet Health that increase access for patients with depression to receive transcranial magnetic stimulation (TMS),...
Neutral
GlobeNewsWire
etwa ein Monat alt
MALVERN, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced certain preliminary unaudited fourth quarter and full year 2023 results.
Neutral
GlobeNewsWire
2 Monate alt
New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers
Neutral
GlobeNewsWire
3 Monate alt
Technological advances reduce time and increase efficiency for MDD treatment Technological advances reduce time and increase efficiency for MDD treatment
Neutral
GlobeNewsWire
3 Monate alt
MALVERN, Pa., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the 35th Annual Piper Sandler Healthcare Conference on Wednesday, November 29, 2023. Th...
Neutral
GlobeNewsWire
3 Monate alt
New updates designed to advance practice efficiency and patient outcomes New updates designed to advance practice efficiency and patient outcomes
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen